Portosystemic shunt (PSS) in dogs is a hereditary condition that impairs liver function, making proper management and careful selection of supplements essential. This article outlines the best products and key criteria to help you manage PSS effectively.






| Item | Product Name | Form | Main Ingredients | Reason for Recommendation |
|---|---|---|---|---|
| BEST 1 | Liver care probiotic capsule | Capsule | Probiotics, dietary fiber | Supports intestinal nitrogen excretion and relief of ammonia burden |
| BEST 2 | Liver care diet food | Stick type | Optimized protein control, dietary fiber | Manages hepatic encephalopathy with appropriate protein and fiber |
| BEST 3 | Liver care liquid supplement | Liquid | Dietary fiber, probiotics | Easy to administer, so low refusal rate |
Choose according to body weight and condition after consulting a veterinarian.
Caution: Excessive Protein Intake Can Worsen PSS Condition
In dogs with portosystemic shunts, liver function is impaired, so feeding excessive amounts of protein that are hard to process—such as red meat, fish, or organ meats—can increase toxic substances like ammonia and worsen symptoms. However, rather than strictly limiting protein, it is important to adjust the amount under veterinary guidance, providing an appropriate quantity (for example, starting at approximately 2.5 g/kg and adjusting to the level the dog can tolerate) of highly digestible protein.


A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.
Share
[1] Fowler, L.B. et al. (2020). Ecological level analysis of primary lung tumors in dogs and cats and environmental radon activity. J Vet Intern Med 34(6):2660–2670.
[2] Worley, D.R. (2014). Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures. Vet Comp Oncol 12:215–226.
[3] Yoshida, K. et al. (1999). Clinicopathological study of canine oral epulides. J Vet Med Sci 61:897–902.